<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02972281</url>
  </required_header>
  <id_info>
    <org_study_id>2014_07</org_study_id>
    <secondary_id>2014-A00739-38</secondary_id>
    <nct_id>NCT02972281</nct_id>
  </id_info>
  <brief_title>Systematic Search for Primary Immunodeficiency in Adults With Infections</brief_title>
  <acronym>SPIDAC</acronym>
  <official_title>Systematic Search for Primary Immunodeficiency in Adults With Unexplained Recurrent and/or Severe Infections With Encapsulated Bacteria</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Lille</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Imagine Institute</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Octapharma</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>CSL Behring</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Laboratoire français de Fractionnement et de Biotechnologies</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Air Liquide SA</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>The Binding Site Ltd</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital, Lille</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Antibody deficiencies and complement deficiencies are the most frequent Primary
      immunodeficiencies (PIDs) in adults, and are associated with greatly increased susceptibility
      to recurrent and/or severe bacterial infections - especially upper and lower respiratory
      tract infections and meningitis. The literature data suggest that PIDs are under-diagnosed in
      adults. The current European and US guidelines advocate screening adults for PIDs if they
      present recurrent benign especially upper and lower respiratory tract infections, or if they
      have experienced at least two severe bacterial infections and/or have a recurrent need for
      intravenous antibiotics. The objective of the demonstrate the interest of PIDs screening in
      adult patients who present such recurrent infections and/or after the first severe bacterial
      infection, especially when the patients do not present with known, etiologically relevant
      comorbidities.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>March 2015</start_date>
  <completion_date type="Anticipated">March 2020</completion_date>
  <primary_completion_date type="Anticipated">March 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Frequency of Primary immunodeficiencies (PIDs) in adult patients with recurrent and/or severe bacterial infection with encapsulated bacteria</measure>
    <time_frame>At 6 months</time_frame>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">240</enrollment>
  <condition>Complement Deficiency</condition>
  <condition>Antibody Deficiency</condition>
  <condition>Chronic Sinus Infection</condition>
  <condition>Meningitis, Bacterial</condition>
  <condition>Pneumonia, Bacterial</condition>
  <condition>Otitis Media</condition>
  <condition>Streptococcal Infection</condition>
  <condition>Neisseria Infections</condition>
  <condition>Haemophilus Influenza</condition>
  <condition>Pneumococcal Infections</condition>
  <arm_group>
    <arm_group_label>Patients with bacterial infections</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Patients with recurrent and/or severe bacterial infections</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Immunological diagnosis tests</intervention_name>
    <description>(Non exhaustive list): hemogram, IgG, A, M, IgG subclasses, complement, vaccinal response to protein and polysaccharide antigens, ...</description>
    <arm_group_label>Patients with bacterial infections</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  18-65 yrs old patients

          -  ≥ 2 bacterial upper or lower respiratory tract infections/years, for at least 2 years,
             or

          -  ≥ 1 severe bacterial upper or lower respiratory tract infection requiring
             hospitalization and IV antibiotics, or

          -  ≥ 1 invasive infection (meningitis, bacteriemia, arthritis) due to Streptococcus
             pneumoniae, group A Streptococcus, Haemophilus influenzae, Neisseria meningitidis or
             Neisseria gonorrhoeae

        Exclusion Criteria:

          -  concomitant, systemic comorbidity that predisposes to infection (solid or
             hematological cancer, diabetes mellitus, severe alcohol or intravenous drug abuse,
             chronic liver or kidney failure, human immunodeficiency virus infection, anatomic or
             functional asplenia, drug-induced 1 neutropenia, or solid organ or hematopoietic stem
             cell transplantation).

          -  the presence of a local predisposing factor: cigarette smoking (&gt; 5 pack-year and/or 5
             cigarettes/day), underlying infection (tuberculosis, influenza…), chronic obstructive
             pulmonary disease, cystic fibrosis or bronchiectasis for pulmonary infections;
             cerebrospinal leak or preceding upper respiratory tract (URT) infections for
             non-meningococcal meningitis; oral, dental or skin condition for GAS infections

          -  use of corticosteroids, non-steroidal anti-inflammatory drugs, immunosuppressants or
             cytotoxic chemotherapeutics

          -  PID diagnosed before the infectious episode in question.

          -  current or recent pregnancy

          -  hospital-acquired infection (including infections of prostheses).
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Guillaume Lefevre, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Lille</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Guillaume Lefevre, MD</last_name>
    <email>guillaume.lefevre@chru-lille.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>CHRU,</name>
      <address>
        <city>Lille</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Guillaume Lefevre, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 21, 2016</study_first_submitted>
  <study_first_submitted_qc>November 21, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 23, 2016</study_first_posted>
  <last_update_submitted>May 15, 2018</last_update_submitted>
  <last_update_submitted_qc>May 15, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 16, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infection</mesh_term>
    <mesh_term>Communicable Diseases</mesh_term>
    <mesh_term>Pneumonia</mesh_term>
    <mesh_term>Immunologic Deficiency Syndromes</mesh_term>
    <mesh_term>Meningitis</mesh_term>
    <mesh_term>Otitis Media</mesh_term>
    <mesh_term>Pneumococcal Infections</mesh_term>
    <mesh_term>Streptococcal Infections</mesh_term>
    <mesh_term>Pneumonia, Bacterial</mesh_term>
    <mesh_term>Sinusitis</mesh_term>
    <mesh_term>Meningitis, Bacterial</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

